想徵求這篇paper
Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40
Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
Diabetes Care February 2013 vol. 36 no. 2 245-250
煩請寄至 notre_dome@livemail.tw
感恩前輩!
--
※ 發信站: 批踢踢實業坊(ptt.cc)
◆ From: 140.116.98.88